Free Webinar: Kinetic Characterization of Covalent Inhibitors on the PHERAstar

Learn how the use of covalent compounds within the pharmaceutical industry can improve drug discovery

29 May 2018
Holly McHugh
Administrator / Office Personnel

Expert insights

Due to safety concerns, the pharmaceutical industry has long avoided covalent drug approaches. More recent success stories have shown that carefully tuned reactivity and specific complementarity of covalent compounds to their target can give rise to drugs with a range of advantages, particularly in the cancer field.

In this upcoming educational webinar, leading scientists will discuss the biochemical strategies for characterizing covalent compounds in vitro, exemplified by the recent discovery of a new covalent inhibitor targeting the hitherto undruggable cancer target USP7.

It will be presented by Dr. Agnes Martin, a principal scientist in the Screening and Compound Profiling group at Cancer Research UK’s Therapeutic Discovery Laboratories, specializing in biochemical and biophysical assay development for small molecule hit identification and validation. She will be joined by Catherine Wark, a senior applications scientist with over 15 years’ experience at BMG Labtech, assisting users with microplate reader and assay optimization.

Register for this webinar to learn how:

  • Covalent compounds can advance drug discovery in the cancer field
  • A new covalent inhibitor can target undruggable USP7
  • How to easily characterize covalent compounds in vitro

Attend the live webinar on Monday, June 4, at:

  • 16:00 BST
  • 17:00 CEST
  • 11:00 EDT
  • 08:00 PDT

If you can’t attend the live event, register to watch the webinar on demand at a time that suits you

Links

Tags

Cell / Tissue CultureCell culture or tissue culture is used to study the biology of cells or tissues and to isolate cellular products in an environment which can be manipulated and well defined. Accurately control your culture environment with bioreactors or culture incubators, bind your cells to a surface or together with an extracellular matrix. Distinguish cell types with differential media or proliferate cells with certain characteristics using selective media. Enrich your media with supplements such as growth factors, sera and vitamins. Find the best cell and tissue culture products, kits and equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Assay AssemblyAssay Assembly is technique used in drug discovery to develop assays to test the cytotoxicity, genotoxicity, or other activities of a compound on a cell. Assay assembly requires chip assembly, a delivery system and a detection and analysis method. Beneficial features of assay kits or automated systems include high-throughput, high speed and sensitivity and low signal to noise ratio.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.Drug Discovery & Development ScreeningCancer ResearchAlthough cancer is often referred to as a single condition, it actually consists of more than 100 different diseases. Microscopy, mass spectrometry, high throughput sequencing and flow cytometry are some of the most common techniques employed in cancer research labs.
Free Webinar: Kinetic Characterization of Covalent Inhibitors on the PHERAstar